EX-99 6 ex-99.txt EXHIBIT 99 EXHIBIT 99 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ MITHRA SAWYER ________________________________________ (signature of holder) Mithra Sawyer ________________________________________ Please Print Name(s) 60,000 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ E H&P INVESTMENTS ________________________________________ (signature of holder) EH&P Investments ________________________________________ Please Print Name(s) 1,359,500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ TIBOR GAJDICS ________________________________________ (signature of holder) Tibor Gajdics ________________________________________ Please Print Name(s) 1,359,500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ DECLAN CLANCY ________________________________________ (signature of holder) Declan Clancy ________________________________________ Please Print Name(s) 1,359,000 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ RAY CAHILL ________________________________________ (signature of holder) Ray Cahill ________________________________________ Please Print Name(s) 1,339,600 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ SHAMMA AZIZ ________________________________________ (signature of holder) Shamma Aziz ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ WILLIAM LEGG ________________________________________ (signature of holder) William Legg ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ HAVANA CONSULTANTS ________________________________________ (signature of holder) Havana Consultants ________________________________________ Please Print Name(s) 6500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ James Adams ________________________________________ (signature of holder) James Adams ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ FRANK ANDERSON ________________________________________ (signature of holder) Frank Anderson ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ ERWIN HAAS ________________________________________ (signature of holder) Erwin Haas ________________________________________ Please Print Name(s) 2000 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ ELEANOR CALDERWOOD ________________________________________ (signature of holder) Eleanor Calderwood ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ DWIGHT CHAN ________________________________________ (signature of holder) Dwight Chan ________________________________________ Please Print Name(s) 1000 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ KENNY CHAN ________________________________________ (signature of holder) Kenny Chan ________________________________________ Please Print Name(s) 1000 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ WARWICK HOLLAND ________________________________________ (signature of holder) Warwick Holland ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ BADRUDIN VISRAM ________________________________________ (signature of holder) Badrudin Visram ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ SPENCER MICHIEL ________________________________________ (signature of holder) Spencer Michiel ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ CHANTAL HILBERT ________________________________________ (signature of holder) Chantal Hilbert ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ TERRI LOPUSHINSKY ________________________________________ (signature of holder) Terry Lopushinsky ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ SONNY S. DOSANJH ________________________________________ (signature of holder) Sonny S. Dosanih ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ KURT JOHNSON ________________________________________ (signature of holder) Kurt Johnson ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ FRANK DEMPSEY ________________________________________ (signature of holder) Frank Dempsey ________________________________________ Please Print Name(s) 5000 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ J. LARMOR ________________________________________ (signature of holder) Jodi. Larmor ________________________________________ Please Print Name(s) 2000 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ DAVID FRANCO ________________________________________ (signature of holder) David Franco ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ KENNETH GALLIE ________________________________________ (signature of holder) Kenneth Gallie ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ TYLER ROTTARE ________________________________________ (signature of holder) Tyler Rottare ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ BONNIE WHELAN ________________________________________ (signature of holder) Bonnie Whelan ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ ANNA KURTYKA ________________________________________ (signature of holder) Anna Kurtyka ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ ASIF VISRAM ________________________________________ (signature of holder) Asif Visram ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ TRAVIS CHARUK ________________________________________ (signature of holder) Travis Charuk ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ JILL HOLLIDAY H.G. ________________________________________ (signature of holder) Jill Holliday H.G. ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ PAUL RASMUSSEN ________________________________________ (signature of holder) Paul Rasmussen ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ GARY STEWART ________________________________________ (signature of holder) Gary Stewart ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ HEATHER MCLAUGHLIN ________________________________________ (signature of holder) Heather Mclaughlin ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ JAMES MOBERG ________________________________________ (signature of holder) James Moberg ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ STEPHEN GAJDICS ________________________________________ (signature of holder) Stephen Gajdics ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ CHRIS LARSON IN TRUST FOR JENNIFER LARSON _____________________________________________ (signature of holder) Chris Larson In Trust For Jennifer Larson _____________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ CHRIS LARSON ________________________________________ (signature of holder) Chris Larson ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ MICHAEL ABEY ________________________________________ (signature of holder) Michael Abey ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ BARB CHARUK ________________________________________ (signature of holder) Barb Charuk ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ A. ROSS GORRELL ________________________________________ (signature of holder) A. Ross Gorrell ________________________________________ Please Print Name(s) 1000 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ MAXINE CLARK ________________________________________ (signature of holder) Maxine Clark ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ SYLVIA GLINSBOCKEL ________________________________________ (signature of holder) Sylvia Glinsbockel ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ ROBERT CHARUK ________________________________________ (signature of holder) Robert Charuk ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ JAMES CHARUK ________________________________________ (signature of holder) James Charuk ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ JILL HOLLIDAY ________________________________________ (signature of holder) Jill Holliday ________________________________________ Please Print Name(s) 60,000 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ AL CHARUK ________________________________________ (signature of holder) Al Charuk ________________________________________ Please Print Name(s) 1,359,500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ PATRICIA FLEMING ________________________________________ (signature of holder) Patricia Fleming ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ RICHARD HAMILTON ________________________________________ (signature of holder) Richard Hamilton ________________________________________ Please Print Name(s) 1500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ DONALD LYONS ________________________________________ (signature of holder) Donald Lyons ________________________________________ Please Print Name(s) 1500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ JULIE FOLLETT ________________________________________ (signature of holder) Julie Follett ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ ASIF VISRAM IN TRUST FOR SHAYANNE VISRAM ____________________________________________ (signature of holder) Asif Visram in trust for Shayanne Visram ____________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned January 31, 2005 Board of Directors BV Pharmaceutical, Inc. 2890 Vassar Street, Suite A Reno, Nevada 89509 Gentlemen: The undersigned, a beneficial owner of the common stock of BV Pharmaceutical, Inc. (the "Company"), par value $.001 per share (the "Common Stock"), understands that the Company has filed with the U.S. Securities and Exchange Commission a registration statement on Form SB-2, File No. 333-113726, (the "Registration Statement"), for the registration of the Company's Common Stock. As part of the disclosure included in the Registration Statement, the Company has affirmatively stated that there will be no trading of the Company's securities until such time as the Company is successfully registers or qualifies the securities in the State of Texas or another state. In order to insure that the aforesaid disclosure is adhered to, the undersigned agrees, for the benefit of the Company, that he/she/it will not offer to sell, assign, pledge, hypothecate, grant any option for the sale of, or otherwise dispose of, directly or indirectly, any shares of Common Stock of the Company owned by him/her/it, or subsequently acquired through the exercise of any options, warrants or rights, or conversion of any other security, or by reason of any stock split or other distribution of stock, or grant options, rights or warrants with respect to any such shares of Common Stock, until the Company successfully registers or qualifies the Securities in the State of Texas or another state. Furthermore, the undersigned will permit all certificates evidencing his/her/its shares to be delivered to the Law Office of Michael J. Morrison, Esq., 1495 Ridgeview Drive, Suite 220, Reno, Nevada 89509, to be held in trust until the securities are register or qualified in the State of Texas or another state, at which time such certificates shall be returned to the undersigned. Very truly yours, /s/ ANTHONY WONG ________________________________________ (signature of holder) Anthony Wong ________________________________________ Please Print Name(s) 500 __________________________ Number of shares of Common Stock owned